Taribavirin hydrochloride is an oral inhibitor of inosine monophosphate dehydrogenase (IMPDH) designed for liver-targeted delivery to treat hepatitis C virus (HCV). Its selective hepatic concentration aims to reduce systemic exposure and the risk of hemolytic anemia associated with similar antivirals. This mechanism supports its investigation in both in vitro virology studies and in vivo preclinical models of HCV infection.
Molecular Weight:
279.68
CAS Number:
[40372-00-7]
Formula:
C8H14ClN5O4
Target:
Others,HBV,HCV Protease
* VAT and and shipping costs not included. Errors and price changes excepted
